Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RWD domain-containing protein 4 (RWDD4) is a protein encoded in humans by the RWDD4 gene, with additional aliases including FAM28A and RWDD4A. It is a member of the RWD domain protein family, which are recognized for roles in protein-protein interactions. The specific function of RWDD4 is not clearly defined, and there is a lack of strong evidence connecting it to defined signaling pathways, enzyme activities, or transporter/receptor functions[9][12]. RWDD4 is a protein-coding gene with broad but low tissue specificity and poorly characterized biological roles. The gene is listed in some databases as being associated with calvarial doughnut lesions with bone fragility, but no definitive disease associations or relevance as a therapeutic target have been established[5][9]. As of now, no known drugs or mechanisms of action target RWDD4, and there are no established uses as a biomarker or known safety concerns in the therapeutic context.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RWD domain-containing protein 4 (RWDD4).